The effects of four BZ receptor ligands in an operant test were compar
ed with a rotarod test. In the operant test, rats were trained to pull
a chain on a schedule that regulates the probability of delivery of f
ood pellets to maintain a steady chain-pulling rate across alh test se
ssion. For the rotarod test, mice were trained to remain on a rotarod
for 2 min. Diazepam (0.1-3.0 mg/kg, i.p) FG 8205 (0.1-3.0 mg/kg, i.p)
quazepam (3.0-60.0 mg/kg, i.p.) and zolpidem (0.3-10.0 mg/kg, i.p.) ea
ch produced dose-related impairments of performance in both the chain-
pulling test and the mouse rotarod test. Furthermore, the impairment i
n performance induced by FG 8205 (10.0 mg/kg, p.o.) was dose-dependent
ly reversed by the BZ receptor antagonist, flumazenil (1.0-10.0 mg/kg,
i.p.), indicating that the chain-pulling deficit was mediated via BZ
receptor activation. Diazepam, FG 8205 and quazepam all had comparable
potencies in both the rotarod assay and the chain-pulling test. Howev
er, zolpidem suppressed the chain-pulling rates at a dose 30-fold lowe
r than that required to induce a significant deficit in the rotarod pe
rformance. As zolpidem is a preferentially sedative compound, this pat
tern of results is consistent with the hypothesis that the chain-pulli
ng test is sensitive to sedation induced by BZ receptor agonists.